Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 22 Apr 2025

RNF180 weakened the lipid droplet formation and subsequent chemoresistance by destabilizing ACC1 and ACLY in esophageal cancer

in Pharmacology of Anti-Cancer Drugs

Ning Li
Dao-Fu Shen
Nan-Chang Yin
Zheng-Guo Cui
Hua-Chuan Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1525431

1,676 views

Original Research

Published on 17 Apr 2025

Targeting PCNA/PARP1 axis inhibits the malignant progression of hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Jipin Li
Tao Yong
Yali Chen
Tingyu Zeng
Kaifeng Zhang
Shuping Wang
Youcheng Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1571786

1,208 views

Original Research

Published on 17 Apr 2025

LINC01559 drives osimertinib resistance in NSCLC through a ceRNA network regulating miR-320a/IGF2BP3 axis

in Pharmacology of Anti-Cancer Drugs

Leidi Xu
Yibo Zhang
Liangliang Xing
Ying Zhou
Ning Chang
Hangtian Xi
Xiangrui Xu
Jian Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1592846

1,308 views

Original Research

Published on 16 Apr 2025

SUMOylation substrate encoding genes as prognostic biomarkers in pancreatic ductal adenocarcinoma with functional assessment of SAF-B2

in Pharmacology of Anti-Cancer Drugs

Xiangjun Wang
Chuanxin Yang
Yangming Liu
Jian Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1532658

1,269 views

Review

Published on 16 Apr 2025

SREBP2 as a central player in cancer progression: potential for targeted therapeutics

in Pharmacology of Anti-Cancer Drugs

Ruiqi Chen
Tianyu Chen
Xiang Li
Junfeng Yu
Min Lin
Siqi Wen
Man Zhang
Jinchi Chen
Bei Yi
Huage Zhong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1535691

1,662 views

Editorial

Published on 16 Apr 2025

Editorial: Multi-omics application in exploring potential biomarkers targeting resistance of anti-cancer drugs

in Pharmacology of Anti-Cancer Drugs

Huan Wang
Jindong Xie
Zhi Tian
Diane S. Allen-Gipson
Hailin Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1594064

1,278 views

Original Research

Published on 16 Apr 2025

Synthesis of a novel mitochondrial fluorescent probe - killing cancer cells in vitro and in vivo

in Pharmacology of Anti-Cancer Drugs

Xiaowen Yang
Yiting Zhan
Yifei Li
Xinzhuang Shen
Yuqiu Ma
Zongjun Liu
Yipeng Liu
Chengjin Liang
Xiaoyuan Zhang
Yehao Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1543559

1,249 views

Editorial

Published on 16 Apr 2025

Editorial: Autophagy and lung cancer therapy: targeted drug development and new emerging technology

in Pharmacology of Anti-Cancer Drugs

Ming Zhang
Yu Wang
Chunhui Yang
Xin You
Yafei Feng
Xianglin Yang
Qi Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1599548

926 views

Review

Published on 15 Apr 2025

Parthenolide: pioneering new frontiers in hematological malignancies

in Pharmacology of Anti-Cancer Drugs

Elmira Zarei
Ayda Zarei
Azadeh Omidkhoda

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1534686

1,184 views

Original Research

Published on 15 Apr 2025

Multiscale screening and identifying specific targets for artesunate in suppressing bladder cancer

in Pharmacology of Anti-Cancer Drugs

Yi Yuan
Guangdi Chu
Qingyue Ma
Zhijuan Liang
Ye Liang
Haitao Niu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1584502

1,509 views

Case Report

Published on 15 Apr 2025

Case Report: Neoadjuvant therapy with ripretinib for gastrointestinal stromal tumor: a case report

in Pharmacology of Anti-Cancer Drugs

Guanmo Liu
Zicheng Zheng
Jie Li
Yixuan He
Chenggang Zhang
Yihua Wang
Weiming Kang
Xin Ye

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1573610

1,245 views

Original Research

Published on 15 Apr 2025

Integrative analysis of m6A-SNPs and single-cell RNA sequencing reveals key drivers of endocrine combined with CDK4/6 inhibitor therapy resistance in ER+ breast cancer

in Pharmacology of Anti-Cancer Drugs

Ruijie Ming
Han Zhang
Huan Wu
Fangbiao Zhan
Xiaoping Huang
Huawen Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1590363

1,464 views

Original Research

Published on 14 Apr 2025

Dehydroleucodine exerts an antiproliferative effect on human Burkitt’s lymphoma Daudi cells via SLC7A11-mediated ferroptosis

in Pharmacology of Anti-Cancer Drugs

Rui Shen
Fang Cheng
Rui Guo
Wenjing Wang
Xiaolong Yang
Yemiao Chen
Yaokai Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1572364

1,011 views

Case Report

Published on 14 Apr 2025

Case Report: A novel ELMOD3-ALK and EML4-ALK double-fusion responses to neoadjuvant alectinib in a lung adenocarcinoma patient

in Pharmacology of Anti-Cancer Drugs

Kaili Huang
Wen Li
Yinyin Xue
Lei Peng
Qiang Wu
Qinghua Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1515826

1,103 views

Original Research

Published on 11 Apr 2025

Integrating multi-omics and experimental techniques to decode ubiquitinated protein modifications in hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Haikun Yang
Yuan Chen
Zheng Zhou
Yanjing Wang
Peng Li
Yang Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1545472

1,672 views

Original Research

Published on 11 Apr 2025

Elucidation of the mechanism Underlying the promotion of ferroptosis and enhanced antitumor immunity by citrus polymethoxyflavones in CRC cells

in Pharmacology of Anti-Cancer Drugs

Yingying Duan
Yu Wu
Jiaqi Tian
Yuqin Yin
Zhongwen Yuan
Wenting Zhu
Suyue Zhou
Chen Li
Senling Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1571178

1,214 views
3 citations